BioCentury
ARTICLE | Company News

VioQuest, Pfizer deal

October 25, 2004 7:00 AM UTC

PFE will use ligand technology from VQPH subsidiary Chiral Quest Inc. for the process development and manufacture of new compounds. Financial terms were not disclosed. ...